These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 35805995)
21. Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response. Xing AY; Wang B; Li YH; Chen X; Wang YW; Liu HT; Gao P Pathol Oncol Res; 2021; 27():1609753. PubMed ID: 34257614 [No Abstract] [Full Text] [Related]
22. Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer. Kawaguchi T; Yan L; Qi Q; Peng X; Edge SB; Young J; Yao S; Liu S; Otsuji E; Takabe K Ann Surg Oncol; 2018 Dec; 25(13):4037-4046. PubMed ID: 30311168 [TBL] [Abstract][Full Text] [Related]
23. A microRNA expression signature as a predictor of survival for colon adenocarcinoma. Xu M; Kuang Y; Wang M; Han X; Yang Q Neoplasma; 2017; 64(1):56-64. PubMed ID: 27881005 [TBL] [Abstract][Full Text] [Related]
24. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data. Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786 [TBL] [Abstract][Full Text] [Related]
25. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. Zhang C; Zhang CD; Ma MH; Dai DQ World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201 [TBL] [Abstract][Full Text] [Related]
26. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer. Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G Gene; 2019 May; 697():86-93. PubMed ID: 30779946 [TBL] [Abstract][Full Text] [Related]
27. Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma. Xin X; Zhang Y; Ling F; Wang L; Sheng X; Qin L; Zhao X Exp Eye Res; 2019 Mar; 180():242-249. PubMed ID: 30615885 [TBL] [Abstract][Full Text] [Related]
28. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling. Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916 [TBL] [Abstract][Full Text] [Related]
29. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma. Li X; Shi Y; Yin Z; Xue X; Zhou B J Transl Med; 2014 Jun; 12():159. PubMed ID: 24893932 [TBL] [Abstract][Full Text] [Related]
30. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration. Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588 [TBL] [Abstract][Full Text] [Related]
31. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus. Xue J; Jia E; Ren N; Xin H Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850 [TBL] [Abstract][Full Text] [Related]
32. Identifying a new microRNA signature as a prognostic biomarker in colon cancer. Lv Y; Duanmu J; Fu X; Li T; Jiang Q PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961 [TBL] [Abstract][Full Text] [Related]
33. Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients. Huo D; Clayton WM; Yoshimatsu TF; Chen J; Olopade OI Oncotarget; 2016 Aug; 7(34):55231-55248. PubMed ID: 27409424 [TBL] [Abstract][Full Text] [Related]
34. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K Front Immunol; 2022; 13():947802. PubMed ID: 36405735 [TBL] [Abstract][Full Text] [Related]
35. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients. Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271 [TBL] [Abstract][Full Text] [Related]
36. A three-microRNA signature predicts clinical outcome in breast cancer patients. Cheng D; He H; Liang B Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6386-6395. PubMed ID: 30338807 [TBL] [Abstract][Full Text] [Related]
37. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma. Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y Front Immunol; 2022; 13():994019. PubMed ID: 36177006 [TBL] [Abstract][Full Text] [Related]
38. Recurrence prediction using microRNA expression in hormone receptor positive breast cancer during tamoxifen treatment. Kim C; Go EJ; Kim A Biomarkers; 2018 Dec; 23(8):804-811. PubMed ID: 30010434 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851 [TBL] [Abstract][Full Text] [Related]